Lok AS - Search Results

1

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.

Dienstag JL, Ghany MG, Morgan TR, Di Bisceglie AM, Bonkovsky HL, Kim HY, Seeff LB, Szabo G, Wright EC, Sterling RK, Everson GT, Lindsay KL, Lee WM, Lok AS, Morishima C, Stoddard AM, Everhart JE; HALT-C Trial Group. Dienstag JL, et al. Among authors: lok as. Hepatology. 2011 Aug;54(2):396-405. doi: 10.1002/hep.24370. Epub 2011 Jun 23. Hepatology. 2011. PMID: 21520194 Free PMC article. Clinical Trial.

2

Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.

Lok AS, Lai CL, Chung HT, Lau JY, Leung EK, Wong LS. Lok AS, et al. Hepatology. 1991 May;13(5):834-7. doi: 10.1002/hep.1840130506. Hepatology. 1991. PMID: 1709410

3

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection.

Lok AS, Lai CL, Leung EK. Lok AS, et al. Hepatology. 1990 Dec;12(6):1266-70. doi: 10.1002/hep.1840120603. Hepatology. 1990. PMID: 2258142 Clinical Trial.

4

alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.

Lok AS, Lai CL. Lok AS, et al. Hepatology. 1989 Jan;9(1):110-5. doi: 10.1002/hep.1840090119. Hepatology. 1989. PMID: 2461890

5

A young woman with cirrhosis: autoimmune hepatitis vs. alpha 1-antitrypsin deficiency.

Lok AS, Ghany MG, Gerber MA. Lok AS, et al. Hepatology. 1994 May;19(5):1302-6. Hepatology. 1994. PMID: 8175155 No abstract available.

6

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS. Ghany MG, et al. Among authors: lok as. Dig Dis Sci. 1996 Jun;41(6):1265-72. doi: 10.1007/BF02088247. Dig Dis Sci. 1996. PMID: 8654162 Free article.

7

Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection.

Ghany MG, Chan TM, Sanchez-Pescador R, Urdea M, Lok AS. Ghany MG, et al. Among authors: lok as. Dig Dis Sci. 1996 Nov;41(11):2213-8. doi: 10.1007/BF02071402. Dig Dis Sci. 1996. PMID: 8943974 Free article.

8

Combination therapy for chronic hepatitis B.

Fontana RJ, Lok AS. Fontana RJ, et al. Among authors: lok as. Hepatology. 1997 Jul;26(1):234-7. doi: 10.1002/hep.510260133. Hepatology. 1997. PMID: 9214476 No abstract available.

9

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Ghany MG, et al. Among authors: lok as. Hepatology. 1998 Jan;27(1):213-22. doi: 10.1002/hep.510270133. Hepatology. 1998. PMID: 9425940 Free article.

10

Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B.

Lok AS, Ghany MG, Watson G, Ayola B. Lok AS, et al. J Viral Hepat. 1998 May;5(3):171-8. doi: 10.1046/j.1365-2893.1998.00098.x. J Viral Hepat. 1998. PMID: 9658370 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

620 results

Search Page